Astellas Pharma Inc (OTC Pink - Limited Information:ALPMF)
| 11.81 Delayed Data As of Dec 05 |  +0.031 / +0.26%Today’s Change | 11.56 Today|||52-Week Range 17.00 | -24.17% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $22.1B |
Company Description
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Contact Information
Astellas Pharma, Inc. 2-5-1 Nihonbashi-Honcho Tokyo Tokyo 103-8411 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Naoki Okamura | President, CEO & Representative Director |
| Kitamura Atsushi | Chief Financial Officer |
| Tadaaki Taniguchi | Chief Medical Officer |
| Yoshitsugu Shitaka | Chief Scientific Officer & Head-Research |
| Katsuyoshi Sugita | EVP, Chief People, Ethics & Compliance Officer |
